‘Raising the bar’
As published in the BMJ, 29 February 2024:
being and becoming in the world
As published in the BMJ, 29 February 2024:
RCPsych in Scotland is the professional medical body for psychiatry in Scotland and “set standards and promote excellence in psychiatry and mental healthcare.” The next continuing medical educational event for … Continue reading ‘Medicines on the horizon’
Confirmed symposia for next year’s Summer Meeting of the British Association for Psychopharmacology [BAP] indicate an increasing defensiveness: BAP ‘symposia’ are generally sponsored by the pharmaceutical industry. BAP meetings continue … Continue reading ‘Preliminary’
The opening address at this forthcoming event is by the President of the Royal College of Psychiatrists: This is a summary of what the event will cover: This RCPsych Continuing … Continue reading New Beginnings
Each summer the British Association for Psychopharmacology (BAP) has a Summer Meeting that provides accredited continuing medical education [CME] for psychiatrists and academics. It is hugely popular. A colleague of mine … Continue reading “BAPFEST”
The British Association for Psychopharmacology [BAP] provides this policy on relations with industry and other organisations. BAP confirms that this policy was agreed by BAP Council in July 2019 and … Continue reading BAP relationship with industry
At the forthcoming 2023 Summer Meeting of the British Association for Psychopharmacology [BAP] one of the ‘workshops’ for trainee doctors is titled ‘Public engagement – tips for best practice‘. Former … Continue reading Paid opinion leaders on public engagement
For UK psychiatrists the British Association for Psychopharmacology [BAP] is considered the premier educational resource. At the forthcoming 2023 Summer Meeting there are a number of ‘Satellite Symposia” sponsored by … Continue reading Yet more “education” funded by Industry